Background: COVID-19 vaccination is still accepted by only half of pregnant women. Further scientific evidence on the safety of the COVID-19 vaccine could help overcome vaccine hesitancy in this ...
Background: Donafenib is an approved multikinase inhibitor for hepatocellular carcinoma (HCC). However, cutaneous toxicity—particularly hand–foot skin reaction (HFSR)—may necessitate treatment ...
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback